Sun Pharma Advanced Research Company Ltd announced the grant of an exclusive license to Tripoint Therapeutics LLC, USA (Tripoint) to commercialize ElepsiaTM XR 1000 mg and ElepsiaTM XR 1500 mg tablets in the USA.
source https://www.pharmatutor.org/pharma-news/2020/sparc-licenses-commercialization-rights-of-elepsiatm-xr-to-tripoint-therapeutics
No comments:
Post a Comment